NORTHWEST BIOTHERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Northwest Biotherapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Northwest Biotherapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $689K, a 57.5% decline year-over-year.
  • Northwest Biotherapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.56M, a 15.5% decline year-over-year.
  • Northwest Biotherapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $4.41M, a 64.2% decline from 2022.
  • Northwest Biotherapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $12.3M, a 21% decline from 2021.
  • Northwest Biotherapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $15.6M, a 70% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.56M $689K -$933K -57.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $5.49M $1.13M +$850K +307% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $4.64M $1.16M +$231K +24.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $4.41M $1.58M -$981K -38.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $5.39M $1.62M -$1.74M -51.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $7.13M $277K -$5.49M -95.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $12.6M $933K +$316K +51.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $12.3M $2.56M +$1.62M +172% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $10.7M $3.36M +$2.1M +166% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $8.58M $5.76M +$2.21M +62.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $6.37M $617K -$9.2M -93.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $15.6M $939K -$11.7M -92.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $27.3M $1.26M -$37.6M -96.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $64.9M $3.55M +$3.52M +10046% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $61.4M $9.82M +$9.45M +2597% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $52M $12.6M +$12.4M +4802% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $39.6M $38.9M +$38.3M +6702% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.23M $35K -$403K -92% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $1.63M $364K -$189K -34.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $1.82M $258K -$732K -73.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $2.55M $572K -$885K -60.7% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-15
Q2 2019 $3.44M $438K -$11.1M -96.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $14.6M $553K +$283K +105% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-24
Q4 2018 $14.3M $990K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $1.46M +$1.34M +1124% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $11.6M +$11.2M +3002% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $270K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $119K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 $373K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2015 $12.6M $6.4M +$3.9M +156% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $8.7M $2.6M +$2.6M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-16
Q3 2014 $6.1M $900K +$769K +587% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-19
Q2 2014 $5.33M $2.7M +$2.09M +343% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-15
Q1 2014 $3.24M $2.5M +$1.89M +311% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $1.35M $0 -$629K -100% Oct 1, 2013 Dec 31, 2013 10-K 2014-04-01
Q3 2013 $1.98M $131K -$546K -80.7% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-15
Q2 2013 $2.53M $610K -$245K -28.7% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $2.77M $609K -$433K -41.6% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $3.2M $629K Oct 1, 2012 Dec 31, 2012 10-K 2014-04-01
Q3 2012 $677K -$727K -51.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 $855K -$4.6M -84.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $1.04M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $1.4M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $5.46M Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.